Rapport Therapeutics prices $250M stock at $26 per share

2 hours ago 1

Rapport Therapeutics (NASDAQ:RAPP) priced an underwritten public offering of 9.62M shares at a public offering price of $26.00 per share.
The underwriters have a 30-day option to purchase up to an additional 1.44M shares.
The gross proceeds from the offering